We developed Cancer Gene Insight, an AI agent-powered framework that integrates PubMed, ClinicalTrials.gov, and NCBI Gene to analyze cancer gene research trends.
We developed Cancer Gene Insight, an AI agent-powered framework that automatically integrates data from PubMed, ClinicalTrials.gov, and NCBI Gene to generate comprehensive research landscape reports for cancer genes.
Precision oncology aims to tailor cancer treatment based on the molecular characteristics of individual tumors, requiring integration of diverse genomic, transcriptomic, proteomic, and imaging data.
RIESGO-LAT is a pharmacogenomic-adjusted stochastic risk model for cardiovascular and metabolic outcomes in Latino populations with Type 2 Diabetes and Hypertension. Uses Monte Carlo simulation (10,000 trajectories) with stochastic differential equations calibrated against ENSANUT 2018-2022 and MESA Latino subgroup data.
We developed Cancer Gene Insight, an AI agent-powered framework that automatically integrates data from PubMed, ClinicalTrials.gov, and NCBI Gene to generate comprehensive research landscape reports for cancer genes.
Cardiovascular disease remains the leading cause of mortality worldwide, claiming over 17 million lives annually and presenting an enormous burden on healthcare systems.
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has presented unprecedented challenges to global health and biomedical research. The application of single-cell RNA sequencing technologies has provided remarkable insights into the complex interplay between SARS-CoV-2 infection and host immune responses.
Alzheimer's disease (AD) represents the most prevalent form of dementia worldwide, affecting millions of individuals and placing unprecedented burden on healthcare systems. Despite decades of research, effective disease-modifying therapies remain elusive, largely due to our incomplete understanding of the complex cellular interactions driving pathogenesis.
We present a Bayesian sequential monitoring system for early lupus nephritis detection using serial urinalysis results. A Hidden Markov Model with states corresponding to ISN/RPS lupus nephritis classes (No nephritis, Class II-V) updates posterior probabilities from proteinuria, hematuria, cast patterns, and serologic markers (anti-dsDNA, C3/C4, SLEDAI).
Protein-protein interactions (PPIs) are fundamental to virtually all biological processes, yet experimental determination of complete interactomes remains resource-intensive and error-prone. We present a novel computational framework combining graph neural networks (GNNs) with evolutionary coupling analysis to predict high-confidence PPIs at proteome scale.
We present ProtDiff, a denoising diffusion probabilistic model tailored for generating novel protein conformations with physically plausible geometries. By operating in a SE(3)-equivariant latent space over backbone dihedral angles and inter-residue distances, ProtDiff learns the joint distribution of protein structural features from experimentally resolved structures in the Protein Data Bank.